Avobenzone: Effective UVA Filter, Unstable and Absorbed

Is Avobenzone Safe? The Short Answer

Absorption into blood is established; long-term harm is not established by the absorption trials. The FDA testing threshold is the level below which some additional safety studies may be waived, not a level at which harm begins. The FDA's randomized absorption trial measured exposure, called for further safety research, and explicitly said its findings do not mean people should stop using sunscreen.

Avobenzone is a chemical UVA filter. If you prefer mineral UV filters, compare the active ingredients in our mineral sunscreen list.

Chemical Properties and UV Protection

Avobenzone, marketed as Parsol 1789, is a dibenzoylmethane derivative that absorbs UVA radiation in the 320-400 nm range. Permitted at up to 3% in the US, it was the only UVA I chemical filter in the US sunscreen monograph until bemotrizinol was added by final order OTC000039 (effective 9 August 2026), making it essential for broad-spectrum protection in chemical sunscreens.

UV Absorption Spectrum

Avobenzone provides peak absorption at 357 nm, covering the UVA I range (340-400 nm) that penetrates deep into the dermis. This long-wave UVA protection is critical for preventing photoaging, DNA damage, and melanoma. However, avobenzone provides no UVB protection, requiring combination with other filters.

Photostability Challenges

Rapid Photodegradation

Without stabilizers, avobenzone degrades by 50% after just 1 hour of UV exposure, significantly reducing the sunscreen's effectiveness. This photodegradation occurs through keto-enol tautomerization when exposed to UV light, breaking down the molecule and eliminating its protective capacity.

To address instability, manufacturers combine avobenzone with photostabilizers:

• Octocrylene: Most common stabilizer, prevents degradation but adds to chemical load
• Ethylhexyl methoxycrylene: Newer stabilizer with better performance
• Polyester-8: Polymer-based stabilizer reducing skin penetration
• Diethylhexyl syringylidenemalonate: Antioxidant stabilizer

Systemic Absorption Research

Key findings from systemic absorption studies:

• Passes 0.5 ng/mL after a single application on day 1
• Accumulates over four days of repeated maximal use
• Still above 0.5 ng/mL at day 7 in 95% of participants
• Highest from the lotion, not from the sprays

Safety Concerns

Endocrine Disruption Potential

While less studied than oxybenzone, emerging research suggests avobenzone may have endocrine-disrupting properties. Studies have found it can affect androgen and progesterone receptors, though at lower potency than other chemical filters.

Allergic Reactions

Avobenzone is associated with allergic and photoallergic contact dermatitis. The degradation products formed during photodegradation may be more allergenic than the parent compound, particularly in individuals with sensitive skin.

Environmental Impact

Avobenzone has been detected in surface waters and wastewater treatment plants. While not currently banned like oxybenzone, studies show it can bioaccumulate in aquatic organisms and may contribute to coral bleaching at high concentrations.

Regulatory Status

United States: Approved at up to 3% concentration. FDA has requested additional safety data but has not reached a final determination on GRASE (Generally Recognized As Safe and Effective) status.

European Union: Approved at up to 5% concentration. No current restrictions, though under review for potential endocrine effects.

Other regions: Widely approved globally, though some countries are reviewing safety data in light of absorption studies.

Australia: Permitted under TGA regulation (as butyl methoxydibenzoylmethane). The TGA's 2025 safety review found a margin of safety above 100 and considers it low-risk at permitted levels.

Canada: Permitted under Health Canada's Primary Sunscreen Monograph; avobenzone is the standard UVA filter in Canadian chemical sunscreens, as in the US.

Formulation Considerations

Due to its instability and absorption concerns, avobenzone presents formulation challenges:

1. Stabilization requirements: Must be combined with photostabilizers, increasing formula complexity
2. Oil solubility: Requires oil phase or solubilizers in water-based formulas
3. Incompatibilities: Cannot be formulated with mineral sunscreens (degrades faster)
4. Concentration limits: 3% maximum limits UVA protection achievable

What the Absorption Trials Actually Tested

The FDA's maximal-use trials are the strongest evidence on this page, and they describe their sunscreens by formulation type only — lotion, aerosol spray, non-aerosol spray, pump spray. Neither paper names a commercial product, so no brand can be attached to these numbers.

Four further product claims once sat in this section — two photostability comparisons, one in vitro endocrine test and one combination-filter study, each naming a commercial sunscreen. None of their citations resolves to a real paper in PubMed, so all four were removed in September 2026 rather than left with a figure whose source cannot be named.

Alternatives and Recommendations

For those concerned about avobenzone's absorption and stability issues, alternatives include:

• Zinc oxide sunscreens: Provides stable, broad-spectrum protection without absorption
• Titanium dioxide + zinc oxide: Combination for full UV coverage
• Newer UVA filters: Mexoryl SX (ecamsule, sold in the US only under L'Oréal NDAs) and Mexoryl XL (not approved in the US) offer better stability
• Physical barriers: Clothing, hats, and shade remain most effective

Given the systemic absorption data and photostability challenges, individuals may want to minimize avobenzone exposure, particularly with daily use products. When using avobenzone-containing sunscreens, reapplication every 2 hours is essential due to photodegradation.

Recommended: La Roche-Posay Anthelios Mineral Sunscreen SPF 50 — an avobenzone-free mineral alternative — photostable zinc oxide and titanium dioxide